journal article·2025-05-13Open access

Lymph Node Involvement Prediction Using Machine Learning: Analysis of Prostatic Nodule, Prostatic Gland, and Periprostatic Adipose Tissue (PPAT)

Eliodoro Faiella, Giulia D’amone, Raffaele Ragone, Matteo Pileri, Elva Vergantino, Bruno Beomonte Zobel, Rosario Francesco Grasso, Domiziana Santucci

Applied Sciences· Volume 15· Issue 10

Abstract

Background: Prostate cancer is a major cause of cancer-related mortality among men, with approximately 15% of newly diagnosed patients having pelvic lymph node metastasis (PLNM). For this reason, PLNM identification before localized PCa treatment would significantly impact treatment planning, clinical judgment, and patient outcome prediction. Radiomics has gained popularity for its ability to predict tumor behavior and prognosis without invasive procedures. Magnetic resonance imaging (MRI) is widely used in radiomic workups, particularly for prostate cancer. This study aims to predict lymph node invasion in prostate cancer patients using clinical information and mp-MRI radiomics features extracted from the suspicious nodule, prostate gland, and periprostatic adipose tissue (PPAT). Methods: A retrospective review of 85 patients who underwent mp-MRI at our radiology department between 2016 and 2022 was conducted. This study included patients who underwent prostatectomy and lymphadenectomy with complete histological examination and previous staging mp-MRI and were divided into two groups based on lymph node status (positive/negative). Data were collected from each patient, including clinical information, radiomics, and semantic data (such as tumor MRI characteristics, histological tumor details, and lymph node status (LNS)). MRI exams were conducted using a 1.5-T system and were used to study the prostate gland. A three-year resident manually segmented the prostate nodule, prostatic gland, and periprostatic tissue using an open-source segmentation program. A random forest (RF) machine learning model was developed and tested using Chat-GPT version 4.0 software. The model’s performance in predicting LNS was assessed using accuracy, precision, recall, F1 score, and area under the curve (AUC) receiver operating characteristic (ROC), with sensitivity and specificity evaluated using DeLong’s test. Results: Random forest demonstrated the best performance in prediction considering features extracted from DWI nodules (67% of accuracy, 0.83 AUC), from T2 fat (78% of accuracy, 0.86 AUC), and from T2 glands (78% of accuracy, 0.97 AUC). The combination of the three sequences in the nodule evaluation was more accurate compared with the single sequences (88%). Combining all the nodule features with gland and PPAT features, an accuracy of 89% with AUC near 1 was obtained. Compared with the analysis of the nodule and the PPAT, the whole-gland evaluation had the best performance (p ≤ 0.05) in predicting LNS when compared with the nodule. Conclusions: Precise nodal staging is essential for PCa patients’ prognosis and therapeutic strategy. When compared with a radiologist’s assessment, radiomics models enhance the diagnostic accuracy of lymph node staging for prostate cancer. Although data are still lacking, deep learning models may be able to further improve on this.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Prostate Cancer Diagnosis and Treatment · Radiomics and Machine Learning in Medical Imaging · AI in cancer detection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Unit of Radiology and Interventional Radiology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 00128 Rome, Italy

Research Unit of Radiology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 00128 Rome, Italy

References (41)

Show source-provided references
1. Prostate Cancer, Version 1.201610.6004/jnccn.2016.0004 ↗
2. Mortality Rate Estimation Models for Patients with Prostate Cancer Diagnosis
3. Cancer statistics, 202310.3322/caac.21763 ↗
4. Radiomics MRI for lymph node status prediction in breast cancer patients: The state of art10.1007/s00432-021-03606-6 ↗
5. Pelvic Lymph Node Dissection in Prostate Cancer: Indications, Extent and Tailored Approaches10.5301/uro.5000139 ↗
6. Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D’Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study10.1097/JU.0000000000000504 ↗
7. The role of data science in healthcare advancements: Applications, benefits, and future prospects10.1007/s11845-021-02730-z ↗
8. Santucci, D., Faiella, E., Cordelli, E., Sicilia, R., de Felice, C., Zobel, B.B., Iannello, G., and Soda, P. (2021). 3T MRI-Radiomic Approach to Predict for Lymph Node Status in Breast Cancer Patients. Cancers, 13.10.3390/cancers13092228 ↗
9. Radiomics and artificial intelligence in prostate cancer: New tools for molecular hybrid imaging and theragnostics10.1186/s41747-022-00282-0 ↗
10. Faiella, E., Santucci, D., Calabrese, A., Russo, F., Vadalà, G., Zobel, B.B., Soda, P., Iannello, G., de Felice, C., and Denaro, V. (2022). Artificial Intelligence in Bone Metastases: An MRI and CT Imaging Review. Int. J. Environ. Res. Public Health, 19.10.3390/ijerph19031880 ↗
11. Santucci, D., Faiella, E., Calabrese, A., Zobel, B.B., Ascione, A., Cerbelli, B., Iannello, G., Soda, P., and de Felice, C. (2021). On the Additional Information Provided by 3T-MRI ADC in Predicting Tumor Cellularity and Microscopic Behavior. Cancers, 13.10.3390/cancers13205167 ↗
12. Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases10.1007/s00261-008-9361-2 ↗
13. Iglesias, Á.S., Macías, V.M., Peris, A.P., Fuster-Matanzo, A., Infante, A.N., Soria, R.M., Bataller, F.B., Pomar, M.D., Meléndez, C.C., and Huertas, R.Y. (2023). Prostate Region-Wise Imaging Biomarker Profiles for Risk Stratification and Biochemical Recurrence Prediction. Cancers, 15.10.3390/cancers15164163 ↗
14. Impact of adipose tissue distribution on prostate cancer recurrence after radical prostatectomy10.1016/j.acuro.2021.12.015 ↗
15. Faiella, E., Vaccarino, F., Ragone, R., D’amone, G., Cirimele, V., Piccolo, C.L., Vertulli, D., Grasso, R.F., Zobel, B.B., and Santucci, D. (2023). Can Machine Learning Models Detect and Predict Lymph Node Involvement in Prostate Cancer? A Comprehensive Systematic Review. J. Clin. Med., 12.10.3390/jcm12227032 ↗
16. Faiella, E., Vergantino, E., Vaccarino, F., Bruno, A., Perillo, G., Grasso, R.F., Zobel, B.B., and Santucci, D. (2024). A Review of the Paradigmatic Role of Adipose Tissue in Renal Cancer: Fat Measurement and Tumor Behavior Features. Cancers, 16.10.3390/cancers16091697 ↗
17. The Current State of MR Imaging–targeted Biopsy Techniques for Detection of Prostate Cancer10.1148/radiol.2017161684 ↗
18. Prostate cancer detection: Comparison of t2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined10.1080/02841850802004983 ↗
19. Radiological semantics discriminate clinically significant grade prostate cancer10.1186/s40644-019-0272-y ↗
20. Radiomics vs radiologist in prostate cancer. Results from a systematic review10.1007/s00345-023-04305-2 ↗
21. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options10.1016/j.juro.2017.11.095 ↗
22. A narrative review of pelvic lymph node dissection in prostate cancer10.21037/tau-20-729 ↗
23. Liu, X., Tian, J., Wu, J., Zhang, Y., Wang, X., Zhang, X., and Wang, X. (2022). Utility of diffusion weighted imaging-based radiomics nomogram to predict pelvic lymph nodes metastasis in prostate cancer. BMC Med. Imaging, 22.10.1186/s12880-022-00905-3 ↗
24. Will ChatGPT pass the Polish specialty exam in radiology and diagnostic imaging? Insights into strengths and limitations10.5114/pjr.2023.131215 ↗
25. Diffusion-weighted imaging (DWI) in lymph node staging for prostate cancer10.21037/tau.2018.08.04 ↗
26. Artificial intelligence for the diagnosis of lymph node metastases in patients with abdominopelvic malignancy: A systematic review and meta-analysis10.1016/j.artmed.2021.102022 ↗
27. Radiomics in prostate cancer: An up-to-date review10.1177/17562872221109020 ↗
28. Radiomics and radiogenomics of prostate cancer10.1007/s00261-018-1660-7 ↗
30. Chen, S., Jian, T., Chi, C., Liang, Y., Liang, X., Yu, Y., Jiang, F., and Lu, J. (2022). Machine Learning-Based Models Enhance the Prediction of Prostate Cancer. Front. Oncol., 12.10.3389/fonc.2022.941349 ↗
31. Detection of prostate cancer in multiparametric MRI using random forest with instance weighting10.1117/1.JMI.4.2.024506 ↗
32. Periprostatic Adipose Tissue: A New Perspective for Diagnosing and Treating Prostate Cancer10.7150/jca.89750 ↗
33. Passos, G.R., Ghezzi, A.C., Antunes, E., de Oliveira, M.G., and Mónica, F.Z. (2021). The Role of Periprostatic Adipose Tissue on Prostate Function in Vascular-Related Disorders. Front. Pharmacol., 12.10.3389/fphar.2021.626155 ↗
34. Periprostatic Adipose Tissue and Prostate Cancer Progression: New Insights into the Tumor Microenvironment10.1016/j.clgc.2013.07.013 ↗
35. Sacca, P.A., and Calvo, J.C. (2022). Periprostatic Adipose Tissue Microenvironment: Metabolic and Hormonal Pathways During Prostate Cancer Progression. Front. Endocrinol., 13.10.3389/fendo.2022.863027 ↗
36. Ribeiro, R., Monteiro, C., Catalán, V., Hu, P., Cunha, V., Rodríguez, A., Gómez-Ambrosi, J., Fraga, A., Príncipe, P., and Lobato, C. (2012). Obesity and prostate cancer: Gene expression signature of human periprostatic adipose tissue. BMC Med., 10.10.1186/1741-7015-10-108 ↗
37. Periprostatic Adipose Tissue MRI Radiomics-Derived Features Associated with Clinically Significant Prostate Cancer10.1089/end.2023.0215 ↗
38. Comparing the Diagnostic Performance of Multiparametric Prostate MRI Versus 68Ga-PSMA PET-CT in the Evaluation Lymph Node Involvement and Extraprostatic Extension10.1016/j.acra.2020.07.011 ↗
39. Obesity and prostate cancer—Microenvironmental roles of adipose tissue10.1038/s41585-023-00764-9 ↗
40. Zhao, W., Hou, M., Wang, J., Song, D., and Niu, Y. (2024). Interpretable machine learning model for predicting clinically significant prostate cancer: Integrating intratumoral and peritumoral radiomics with clinical and metabolic features. BMC Med. Imaging, 24.10.1186/s12880-024-01548-2 ↗
41. Santucci, D., Ragone, R., Vergantino, E., Vaccarino, F., Esperto, F., Prata, F., Scarpa, R.M., Papalia, R., Zobel, B.B., and Grasso, F.R. (2024). Comparison between Three Radiomics Models and Clinical Nomograms for Prediction of Lymph Node Involvement in PCa Patients Combining Clinical and Radiomic Features. Cancers, 16.10.3390/cancers16152731 ↗